[{"indications": "Indications\u00a0invasive aspergillosis (see notes above); fusariosis either unresponsive to, or in patients intolerant\r\nof, amphotericin; chromoblastomycosis and mycetoma either unresponsive\r\nto, or in patients intolerant of,  itraconazole; coccidioidomycosis\r\neither unresponsive to, or in patients intolerant of, amphotericin,\r\nitraconazole, or fluconazole; see also under Dose", "name": "POSACONAZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.2 Antifungal drugs", "5.2.1 Triazole antifungals"], "cautions": "Cautions\u00a0cardiomyopathy, bradycardia, symptomatic arrhythmias, history of QT interval prolongation, concomitant use with other drugs known to cause QT-interval prolongation; monitor electrolytes (including potassium, magnesium,\r\nand calcium) before and during therapy, monitor liver function; interactions: Appendix 1 (antifungals, triazole)", "side-effects": "Side-effects\u00a0gastro-intestinal disturbances (including nausea,\r\nvomiting, abdominal pain, diarrhoea, dyspepsia, and flatulence); dizziness,\r\nheadache, paraesthesia, drowsiness, fatigue, fever, anorexia; blood\r\ndisorders (including anaemia, neutropenia, and thrombocytopenia),\r\nelectrolyte disturbances; dry mouth; rash; less commonly pancreatitis, hepatic disorders, arrhythmias, palpitation, changes\r\nin blood pressure, oedema, convulsions, neuropathy, tremor, hyperglycaemia,\r\nmenstrual disorders, renal failure, musculoskeletal pain, visual disturbances,\r\nmouth ulcers, and alopecia; rarely ileus, cardiac\r\nfailure, myocardial infarction, stroke, thrombosis, syncope, pneumonitis,\r\npsychosis, depression, encephalopathy, adrenal insufficiency, breast\r\npain, hearing impairment, and Stevens-Johnson syndrome", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129707.htm", "doses": ["400\u00a0mg twice daily with food or if food\r\nnot tolerated, 200\u00a0mg 4 times daily", "Oropharyngeal candidiasis (severe infection or in immunocompromised\r\npatients only), 200\u00a0mg with food on first day, then 100\u00a0mg once daily\r\nwith food for 13 days", "Prophylaxis of invasive fungal infections in patients undergoing\r\nbone-marrow transplantation or receiving chemotherapy for acute myeloid\r\nleukaemia and myelodysplastic syndrome who are expected to become\r\nneutropenic, and who are intolerant of fluconazole or itraconazole,\r\n200\u00a0mg 3 times daily with food, starting before transplantation or\r\nbefore chemotherapy and continued until neutrophil count recovers", "child under 18 years not recommended"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid unless potential benefit\r\noutweighs risk and recommends effective contraception during treatment;\r\ntoxicity in animal studies"}]